Matthew Herder

647 total citations
55 papers, 346 citations indexed

About

Matthew Herder is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Matthew Herder has authored 55 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Economics and Econometrics, 17 papers in Public Health, Environmental and Occupational Health and 17 papers in Pharmacology. Recurrent topics in Matthew Herder's work include Pharmaceutical Economics and Policy (18 papers), Biomedical Ethics and Regulation (17 papers) and Pharmaceutical industry and healthcare (17 papers). Matthew Herder is often cited by papers focused on Pharmaceutical Economics and Policy (18 papers), Biomedical Ethics and Regulation (17 papers) and Pharmaceutical industry and healthcare (17 papers). Matthew Herder collaborates with scholars based in Canada, United States and United Kingdom. Matthew Herder's co-authors include Janice Graham, Kelly Holloway, E. Richard Gold, Françoise Βaylis, Joseph S. Ross, Joel Lexchin, Keith R. Brunt, Lynette Reid, Eve A. Roberts and Jocelyn Downie and has published in prestigious journals such as Nature Medicine, PLoS ONE and Journal of Business Ethics.

In The Last Decade

Matthew Herder

51 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Herder Canada 11 139 93 61 48 35 55 346
Neil McAuslane United Kingdom 15 447 3.2× 76 0.8× 66 1.1× 76 1.6× 59 1.7× 59 578
Merrill Goozner United States 11 108 0.8× 152 1.6× 46 0.8× 143 3.0× 17 0.5× 24 572
Ekaterina Galkina Cleary United States 8 162 1.2× 53 0.6× 20 0.3× 36 0.8× 10 0.3× 16 383
Alexander C. Egilman United States 10 164 1.2× 41 0.4× 37 0.6× 33 0.7× 33 0.9× 22 290
Tim Reed Netherlands 10 102 0.7× 64 0.7× 33 0.5× 55 1.1× 48 1.4× 23 308
Hilde Stevens Belgium 9 102 0.7× 49 0.5× 28 0.5× 18 0.4× 18 0.5× 21 252
Daniel Tobias Michaeli Germany 14 291 2.1× 61 0.7× 26 0.4× 17 0.4× 51 1.5× 48 550
Sue Hill United Kingdom 9 72 0.5× 130 1.4× 83 1.4× 60 1.3× 34 1.0× 21 565
John C. W. Lim Singapore 8 122 0.9× 68 0.7× 22 0.4× 6 0.1× 26 0.7× 20 236
Signe Mežinska Latvia 9 69 0.5× 88 0.9× 28 0.5× 67 1.4× 29 0.8× 25 245

Countries citing papers authored by Matthew Herder

Since Specialization
Citations

This map shows the geographic impact of Matthew Herder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Herder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Herder more than expected).

Fields of papers citing papers by Matthew Herder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Herder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Herder. The network helps show where Matthew Herder may publish in the future.

Co-authorship network of co-authors of Matthew Herder

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Herder. A scholar is included among the top collaborators of Matthew Herder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Herder. Matthew Herder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herder, Matthew, et al.. (2026). The United States is driving a public health emergency of international concern. BMJ. 392. e089474–e089474.
2.
3.
Herder, Matthew & Srinivas Murthy. (2024). Clinical trial registration and results reporting: a call for transparency, coordination, and meaningful enforcement. Canadian Medical Association Journal. 196(18). E628–E629.
4.
5.
Sud, Abhimanyu, et al.. (2022). Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada. International Journal of Drug Policy. 105. 103749–103749. 5 indexed citations
6.
Egilman, Alexander C., Joseph S. Ross, & Matthew Herder. (2021). Optimizing the data available via Health Canada’s clinical information portal. Canadian Medical Association Journal. 193(33). E1305–E1306. 3 indexed citations
7.
Herder, Matthew, et al.. (2021). From sandbox to pandemic: Agile reform of Canadian drug regulation. Health Policy. 125(9). 1115–1120. 12 indexed citations
8.
Herder, Matthew, Janice Graham, & E. Richard Gold. (2020). From Discovery to Delivery: Public Sector Development of the rVSV-ZEBOV Ebola Vaccine. SSRN Electronic Journal. 1 indexed citations
9.
Herder, Matthew, Janice Graham, & E. Richard Gold. (2019). From discovery to delivery: public sector development of the rVSV-ZEBOV Ebola vaccine. Journal of Law and the Biosciences. 7(1). lsz019–lsz019. 21 indexed citations
10.
Herder, Matthew. (2017). What Is the Purpose of the Orphan Drug Act?. PLoS Medicine. 14(1). e1002191–e1002191. 49 indexed citations
11.
Herder, Matthew. (2016). Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada. Journal of Law and the Biosciences. 3(1). 158–166. 5 indexed citations
12.
Herder, Matthew. (2015). Denaturalizing Transparency in Drug Regulation. SSRN Electronic Journal. 82. 3 indexed citations
13.
Roberts, Eve A., Matthew Herder, & Aidan Hollis. (2015). Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy. Canadian Medical Association Journal. 187(6). 422–425. 11 indexed citations
14.
Herder, Matthew. (2014). Government regulators must steward drug transparency. Nature Medicine. 20(8). 806–806. 5 indexed citations
15.
Herder, Matthew. (2014). Toward a Jurisprudence of Drug Regulation. The Journal of Law Medicine & Ethics. 42(2). 244–262. 5 indexed citations
16.
Herder, Matthew. (2013). Emerging Academic Scientists' Exclusionary Encounters with Commercialization Law, Policy, and Practice. SSRN Electronic Journal. 2 indexed citations
17.
Reid, Lynette & Matthew Herder. (2013). The Speakers’ Bureau System: A Form of Peer Selling. SSRN Electronic Journal. 2 indexed citations
18.
Downie, Jocelyn & Matthew Herder. (2013). Reflections on the Commercialization of Research Conducted in Public Institutions in Canada. eYLS (Yale Law School). 7 indexed citations
19.
Herder, Matthew. (2011). Unlocking Health Canada’s cache of trade secrets: mandatory disclosure of clinical trial results. Canadian Medical Association Journal. 184(2). 194–199. 10 indexed citations
20.
Herder, Matthew. (2009). Patents & the progress of personalized medicine: biomarkers research as lens.. PubMed. 18(2). 187–229, 8 p. preceding i. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil McAuslane Breakdown of academic impact, for papers by Merrill Goozner Breakdown of academic impact, for papers by Ekaterina Galkina Cleary Breakdown of academic impact, for papers by Alexander C. Egilman Breakdown of academic impact, for papers by Tim Reed Breakdown of academic impact, for papers by Hilde Stevens Breakdown of academic impact, for papers by Daniel Tobias Michaeli Breakdown of academic impact, for papers by Sue Hill Breakdown of academic impact, for papers by John C. W. Lim Breakdown of academic impact, for papers by Signe Mežinska
Rankless by CCL
2026